Newly launched startup Metablify aims to revolutionize the field of metabolomics by providing researchers with a platform to analyze and identify metabolites in datasets more effectively. Metabolites are small molecules found in cells, tissues, and organisms that play a crucial role in biological processes and could lead to the development of new drugs, biomarkers, and agricultural products.
Founded by plant scientists Ivan Baxter, Allen Hubbard, Louis Connelly, and CEO Michael Bielski, Metablify was born out of the need for better tools to handle the large amounts of metabolomics data generated in experiments. The platform uses LC/MS data processing algorithms to help researchers sift through the myriad of metabolites and focus on the most important ones.
By overlaying data from different metabolite samples in an experiment, Metablify amplifies the signal of the research subject, making it easier to detect and analyze. This technology has the potential to accelerate drug discovery, personalized medicine, and enhance crop yields in agriculture.
With initial funding from DTC and QRM Capital, and grants from the Danforth Center’s proof-of-concept fund, Metablify is now focused on building partnerships and collaborations to further validate its technology. The startup has already won the Big Ideas 3.0 competition and is looking to expand its customer base to serve a variety of industries beyond metabolomics.
The team at Metablify believes that their platform has the potential to uncover valuable information that researchers may have previously missed, leading to new research pathways and innovations in various fields. Ultimately, Metablify aims to provide researchers with a powerful tool to unlock the hidden potential of metabolomics data and drive new discoveries in science and agriculture.
Source
Photo credit agfundernews.com